跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RECARBRIO 500 mg/500 mg/250 mg POLVO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RECARBRIO 500 mg/500 mg/250 mg POLVO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
RECARBRIO 500 mg/500 mg/250 mg POLVO PARA SOLUCION PARA PERFUSION
Merck Sharp & Dohme B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 16, 2020
Approval ID
89790614541a5554
Company
Merck Sharp & Dohme B.V.
Type
Standard
Approval Details
Approval Id
89790614541a5554
Drug Cima Aemps Name
RECARBRIO 500 mg/500 mg/250 mg POLVO PARA SOLUCION PARA PERFUSION
Register Number
1191420001
Holder Company Name
Merck Sharp & Dohme B.V.
Marketing Company Name
Merck Sharp & Dohme De Espana S.A.
Holder Company Detail Path
/organization/merck-sharp-and-dohme-bv
Authorization Date
2020-12-16
Dosage Form
POLVO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
500 mg/500 mg/250 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Merck Sharp & Dohme B.V.
Company Detail Path
/organization/merck-sharp-and-dohme-bv
Company Information
Pharmaceutical Company Name
Merck Sharp & Dohme B.V.
Name En
Merck Sharp & Dohme B.V.
Country Name
Netherlands
Active Ingredients
IMIPENEM MONOHIDRATO
530 mg
CILASTATINA SODICA
531 mg
RELEBACTAM MONOHIDRATO
263 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 16, 2020
Approval ID
89790614541a5554
Type
Standard
Back to CIMA-AEMPS Approvals